This causes high levels of intestinal toxins such as LPS to enter the circulatory system of the host and induce chronic systemic low-grade inflammation, a condition known as “metabolic endotoxemia.” Eventually, long-term chronic inflammation can lead to a series of metabolic diseases such as decreased insulin sensitivity and NAFLD (Yin et al., 2008a). This evidence concerns the gene INS and Other metabolic disease.